'''Exbivirumab''' is a [[human]] [[monoclonal antibody]]<ref>[http://whqlibdoc.who.int/druginfo/INN_2005_list53.pdf WHO Drug Information]</ref> developed for the treatment of [[hepatitis B]] infections.<ref>{{cite journal|last=Shouval|first=D|year=2006|title=Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatits B Virus (Hbv) in Liver Transplant (Lt) Recipients|journal=Hepatology|volume=44|issue=4|doi=10.1002/hep.21395 |pmid=17001593|pages=188Aâ€“700A [196A]|display-authors=etal}}</ref>
